Starting Dose of Benazepril
The recommended starting dose of benazepril is 10 mg once daily for most adults not receiving a diuretic 1.
Dosing Algorithm
Standard Adult Dosing
- Initial dose: 10 mg once daily 1
- Maintenance range: 20-40 mg daily (single dose or divided twice daily) 1
- Maximum studied dose: 80 mg daily (though experience is limited at this dose) 1
The divided twice-daily regimen provides superior trough blood pressure control compared to once-daily dosing at the same total daily dose 1.
Special Populations Requiring Dose Adjustment
Patients on Diuretics
- Start at 5 mg once daily 1
- If blood pressure remains uncontrolled on benazepril alone, add back a low-dose diuretic 1
Renal Impairment (Adults)
- For GFR <30 mL/min/1.73 m² or serum creatinine >3 mg/dL: Start at 5 mg once daily 1
- May titrate up to maximum 40 mg daily 1
- Monitor renal function closely as benazepril can worsen kidney function 1
Pediatric Patients (≥6 years)
- Start at 0.2 mg/kg once daily 1
- Titrate to 0.6 mg/kg once daily as needed 1
- Maximum: 0.6 mg/kg or 40 mg daily (whichever is lower) 1
- Not recommended in children <6 years or with GFR <30 mL/min/1.73 m² 1
Clinical Context from Guidelines
Multiple cardiovascular guidelines support these dosing recommendations. For heart failure with reduced ejection fraction, benazepril starting doses of 6.25-12.5 mg three times daily with target doses of 25-50 mg three times daily have been used in clinical trials 2, 3. However, the FDA-approved dosing for hypertension differs from heart failure dosing schedules.
For post-MI patients with anterior infarction or LV dysfunction (EF ≤0.40), ACE inhibitors should be initiated cautiously, avoiding use in hypotension, renal failure, or hyperkalemia 4. In chronic kidney disease with diabetes, benazepril starting dose of 10 mg daily with goal doses of 20-40 mg daily (in 1-2 divided doses) has been studied 5.
Monitoring Requirements
Within 1-2 weeks of initiation 2:
- Renal function (serum creatinine)
- Serum potassium
- Blood pressure response
This is particularly critical in patients with pre-existing hypotension, hyponatremia, diabetes, azotemia, or those taking potassium supplements 2.
Titration Strategy
Dose escalation should occur gradually if lower doses are well-tolerated, with the goal of reaching target doses used in clinical trials (typically 20-40 mg daily) 2. Research demonstrates a clear dose-response relationship from 10-80 mg once daily, with the trough-to-peak ratio generally exceeding 50%, indicating sustained 24-hour efficacy 6.
Common Pitfalls
- Do not combine with ARBs or direct renin inhibitors - increases hyperkalemia risk without added benefit 7
- Avoid in pregnancy - can cause fetal harm 2
- History of angioedema - absolute contraindication to all ACE inhibitors 2
- Bilateral renal artery stenosis - risk of acute renal failure 7
The 10 mg starting dose balances efficacy with tolerability, as doses as low as 10 mg once daily have demonstrated clinical effectiveness in individual patients 8, while providing room for upward titration if needed.